Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achaogen Inc (NASDAQ:AKAO)

3.41
Delayed Data
As of Apr 28
 -0.01 / -0.29%
Today’s Change
2.59
Today|||52-Week Range
7.74
-40.59%
Year-to-Date

Today’s Trading

Previous close3.42
Today’s open3.43
Day’s range3.39 - 3.57
Volume26,553
Average volume (3 months)78,467
Market cap$63.0M
Dividend yield--
Data as of 04/28/2016

Growth & Valuation

Earnings growth (last year)-4.93%
Earnings growth (this year)-81.21%
Earnings growth (next 5 years)--
Revenue growth (last year)+30.50%
P/E ratioNM
Price/Sales4.00
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
OCRXOcera Therapeutics I...+0.02+0.66%
REPHRecro Pharma Inc0.000.00%
RNNRexahn Pharmaceutica...-0.00-0.39%
MSTXMast Therapeutics In...-0.01-2.97%
Data as of 04/28/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$26.1M
Annual profit (last year)-$27.1M
Net profit margin-103.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class II Director
Kenneth J. Hillan
Chief Operating Officer
Blake Wise
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs